Injection sites, angles and rotation

Subcutaneous means into the layer of fat between the skin and the muscle. It is sparsely supplied with blood, so a depot placed there is absorbed slowly and fairly evenly over hours — a later, flatter peak. That is a feature for almost everything covered on this site: peptides are generally dosed for a sustained signal rather than a spike, and the fat layer is also the least eventful tissue in the body to put a needle into.

Intramuscular means into the belly of a muscle, past the fat. Muscle is richly vascularised, so absorption is faster and the tail is shorter, and muscle will accept a larger volume without complaint. It also involves a longer needle, more anatomy to avoid, and more discomfort.

Which one you use is a property of the compound and the goal, not a preference. Check the monograph for the compound you are on. Where both are listed, subcutaneous is the default and intramuscular is a deliberate choice for speed or for a volume that will not sit comfortably under the skin.

Volume

• SubQ: up to about 1 mL is comfortable in most sites. Beyond that expect stinging, a visible lump and leak-back.
• IM: the deltoid takes about 1 mL; the vastus lateralis and ventrogluteal take considerably more.

In practice, volume almost never decides. A reconstituted peptide dose is usually 0.05–0.5 mL, which is far inside every ceiling above. Site choice is about absorption, comfort and rotation, not capacity.

For subcutaneous work the tool is a U-100 insulin syringe with a fixed 29–31 G needle, either 5/16 in (8 mm) or ½ in (12.7 mm). Higher gauge number means thinner needle: 31 G hurts least, 29 G draws fastest. Gauge decides comfort and flow. Length decides which layer you land in, which is the part that actually matters.

Subcutaneous tissue is not a fixed depth. It runs from a couple of millimetres on a lean abdomen to several centimetres elsewhere on the same person, and it varies by site more than most people expect. That variability, not any particular number, is why the pinch exists: lifting a fold puts a known thickness of fat under the needle regardless of what the rest of you looks like.

The two ways to miss

• Too deep lands in muscle. It stings more, bruises more, and absorbs faster than the protocol assumed. On a lean person, a ½ in needle at 90° with no pinch will reach muscle at several of the sites below.
• Too shallow lands intradermally: a pale raised bleb like a TB test, a burning sting, and a wet needle track when you withdraw. If you see a wheal, that dose went into the skin, not under it.

Angles

• SubQ, ½ in needle, pinched fold: 45–90°. Ninety degrees is fine into a good fold; 45° is the safer default where the fold is thin, which is most people at the thigh and the arm.
• SubQ, 5/16 in needle: 90°, usually without a pinch. The needle is short enough that this is the intended use.
• IM: 22–25 G, 1–1.5 in, straight in at 90°, skin spread flat rather than pinched. The common failure is a needle that is too short to clear the fat and deposits the dose subcutaneously by accident.

A pinch is not a grab. Thumb and two fingers, lifting skin and fat away from the muscle underneath — roughly an inch of tissue, held gently. If you have taken a fistful, you have lifted muscle along with the fat, which defeats the purpose and hurts considerably more. If the fold blanches white, you are squeezing too hard.

Hold the fold through the injection and release it after the needle is out. Letting go early lets the tissue relax around a needle that is still in it, which is both uncomfortable and a way to push liquid back up the track.

Do not pinch for intramuscular. The goal there is the exact opposite: flatten and slightly stretch the skin with your free hand so the route to the muscle is as short and direct as possible.

The tricep is the site where this all falls apart, because you cannot pinch your own upper arm and operate a syringe with the same hand. The workaround is to press the back of the arm against a wall or a door frame to bunch the tissue, or to have someone else pinch for you.

Aspirating means pulling back on the plunger after the needle is in, to check for blood before injecting. Whether to do it is one of the few genuinely unsettled questions in injection technique, so here is the disagreement rather than a false consensus.

• Subcutaneous: essentially nobody aspirates. There is no vessel of consequence in the fat layer, an insulin needle is too short and too fine to give a reliable reading anyway, and pulling back moves the needle inside the tissue, which causes more trauma than it prevents.
• Intramuscular: it depends who you ask. Modern immunisation guidance advises against routine aspiration at the recommended IM sites, on the grounds that those sites were chosen precisely because no large vessel runs through them and that aspirating adds pain. A good deal of nursing practice, and most of the self-injecting community, still aspirates at the gluteal sites — a habit inherited from oil-based intramuscular injections, where an intravascular deposit is genuinely dangerous.

If a clinician has told you to aspirate, do it. If you choose to on your own, hold the pull for five to ten seconds with the needle held completely still, and stop treating a quick flick of the plunger as a check — it is not one.

Inject into the same square inch repeatedly and the tissue responds by building more of itself. Lipohypertrophy is the result: a rubbery, thickened, slightly raised pad of fat and fibrous tissue under the skin, usually painless, often easier to feel than to see. It is the most common long-term complication of self-injection, and it is entirely preventable.

What makes it insidious is the feedback loop. Repeated trauma dulls the local nerve endings, so the affected patch becomes the least painful place to inject — which is exactly why people keep using it, and why the problem grows on its own momentum.

The consequence is absorption. Drug delivered into lipohypertrophic tissue is absorbed unpredictably: sometimes less, sometimes later, sometimes in a delayed burst. This is very well documented in insulin users, where it drives unexplained glucose variability and inflated dose requirements. Peptide dosing is lower in volume and usually less frequent, so the risk is smaller — but the mechanism is identical tissue biology, and there is no reason to think it behaves differently.

Rotation that actually works

• Move at least 1 in (2.5 cm) from your last puncture, every time.
• Work a site systematically — a grid or a clock face within each area — rather than aiming somewhere in the general vicinity.
• Do not return to the same small patch within a couple of weeks. Rotating between regions in a fixed order makes that automatic instead of something you have to remember.
• Keep a given compound to a given region if its absorption profile matters, and rotate within that region. Switching from abdomen to thigh mid-week changes the absorption rate as well as the location.
• Palpate once a month: fingertips flat, sweeping over each area, comparing left against right. You are feeling for firmness and thickening, not looking for it.
• Found a lump? Stop using it entirely. It resolves over months, and only if it is left completely alone.

Avoid injecting into scars, moles, stretch marks, bruises, recently tattooed or inflamed skin, and stay at least 2 in from the navel.

My stack keeps a rotation order per protocol and remembers which site you used last, which is the part nobody reliably does in their head at seven in the morning.

Sixteen sites, eight on each side. The dashed ring on the front view is a true 2 in radius around the navel, drawn to the scale of the figure — it is the exclusion zone at its actual size, not a decoration.

Each of these exists on both the left and the right, and the technique is the same on either side.

Expected

• A pinprick of blood, or none. A small bruise means you caught a capillary.
• Stinging or warmth for a few minutes, more with some compounds than others.
• A small soft bump that disappears within the hour as the depot spreads.
• Mild local redness or itch. Several peptides do this reliably at every site; if yours does, it is a property of the compound rather than of your technique.

Get it looked at

• Pain, redness or swelling that is increasing 24–48 hours later, especially with heat, hardness or fever. That pattern is infection, not a rough injection, and it wants same-day medical attention.
• Red streaking spreading away from the site, or any discharge.
• Bleeding that will not stop after several minutes of firm pressure — worth attention sooner if you take anticoagulants.
• A firm lump at a site that is still there after weeks. That is lipohypertrophy forming. Retire the area and rotate around it.